Generated Narrative: Composition composition-invasive-carcinoma-of-the-breast Profile: US Pathology Composition Laboratory Report Document DiagnosticReport Reference: Diagnostic Report for 'Pathology Synoptic report' for '->Annie Oakley' status: Final type: INVASIVE CARCINOMA OF THE BREAST: Biopsy encounter: Encounter: identifier = http://example.com/fhir/encounters#123; status = finished; class = inpatient encounter (ActCode[9.0.0]#IMP); type = Pathology consultation, comprehensive, records and specimen with report date: 2025-01-01 21:39:30+0000 author: Wise Owl title: INVASIVE CARCINOMA OF THE BREAST: Resection
INVASIVE CARCINOMA OF THE BREAST: Biopsy
INVASIVE CARCINOMA OF THE BREAST: Resection
Specimen Procedure ✓ Needle biopsy __ Fine needle aspiration __ Other (specify): ___________________ __ Not specified Specimen Laterality __ Right ✓ Left __ Not specified +Tumor Site (select all that apply) __ Upper outer quadrant __ Lower outer quadrant __ Upper inner quadrant __ Lower inner quadrant __ Central __ Nipple ✓ Clock position Specify Clock Position (select all that apply) __ 1 o'clock __ 2 o'clock __ 3 o'clock __ 4 o'clock __ 5 o'clock __ 6 o'clock __ 7 o'clock ✓ 8 o'clock __ 9 o'clock __ 10 o'clock __ 11 o'clock __ 12 o'clock __ Specify distance from nipple in Centimeters (cm): _______________ cm __ Other (specify): ___________________ __ Not specified Histologic Type (Note A) __ No residual invasive carcinoma ✓ Invasive carcinoma of no special type (ductal) __ Micro-invasive carcinoma __ Invasive lobular carcinoma __ Invasive carcinoma with mixed ductal and lobular features __ Invasive carcinoma with features of (specify): ___________________ __ Tubular carcinoma __ Invasive cribriform carcinoma __ Mucinous carcinoma __ Invasive micropapillary carcinoma __ Apocrine adenocarcinoma __ Metaplastic carcinoma __ Encapsulated papillary carcinoma with invasion __ Solid papillary carcinoma with invasion __ Intraductal papillary adenocarcinoma with invasion __ Adenoid cystic carcinoma __ Neuroendocrine tumor __ Neuroendocrine carcinoma __ Invasive carcinoma, type cannot be determined: ___________________ __ Other histologic type not listed (specify): ___________________ __ Histologic Type Comment: ___________________ Histologic Grade (Nottingham Histologic Score) (required only if applicable) (Note B) __ Not applicable (no residual carcinoma or microinvasion only) ✓ Nottingham Score Glandular (Acinar) / Tubular Differentiation ✓ Score 1 (greater than 75% of tumor area forming glandular / tubular structures) __ Score 2 (10% to 75% of tumor area forming glandular / tubular structures) __ Score 3 (less than 10% of tumor area forming glandular / tubular structures) __ Score cannot be determined Nuclear Pleomorphism __ Score 1 (Nuclei small with little increase in size in comparison with normal breast epithelial cells, regular outlines, uniform nuclear chromatin, little variation in size) ✓ Score 2 (Cells larger than normal with open vesicular nuclei, visible nucleoli, and moderate variability in both size and shape) __ Score 3 (Vesicular nuclei, often with prominent nucleoli, exhibiting marked variation in size and shape, occasionally with very large and bizarre forms) __ Score cannot be determined Mitotic Rate See Table 1 in CAP Protocol ✓ Score 1 __ Score 2 __ Score 3 __ Score cannot be determined: ___________________ Overall Grade ✓ Grade 1 (scores of 3, 4, or 5) Tumor Size (Note E) __ No residual invasive carcinoma __ Microinvasion only (less than or equal to 1 mm) ✓ Greatest dimension of largest invasive focus greater than 1 mm (specify exact measurement in Millimeters (mm)): 13.0 mm __ Additional Dimension in Millimeters (mm): ____ × ____ mm __ Size of largest invasive focus cannot be determined (explain): ___________________ +Tumor Focality (Note F) ✓ Single focus of invasive carcinoma __ Multiple foci of invasive carcinoma __ Number of Foci __ Specify number: ___________________ __ At least: ___________________ __ Cannot be determined Ductal Carcinoma In Situ (DCIS) (Note G) ✓ Not identified __ Present __ Present (in close proximity to invasive carcinoma) __ Present only after presurgical therapy and prior to therapy the cancer is classified as pTis __ Negative for extensive intraductal component (EIC) __ Positive for extensive intraductal component (EIC) __ Only DCIS is present after presurgical (neoadjuvant) therapy +Size (Extent) of DCIS __ Estimated size (extent) of DCIS is at least in Millimeters (mm): _____ mm __ Additional Dimension in Millimeters (mm): _____ × _____ mm __ Cannot be determined Tumor Extent (Note H) __ Tumor Extent (required only if skin, nipple, or skeletal muscle are present and involved) (select all that apply) ✓ Not applicable (skin, nipple, and skeletal muscle are absent OR are uninvolved) Margin Status for Invasive Carcinoma (required only if residual invasive carcinoma is present in specimen) __ Not applicable (residual invasive carcinoma in specimen is absent) ✓ All margins negative for invasive carcinoma Distance from Invasive Carcinoma to Closest Margin Specify in Millimeters (mm): ✓ Exact distance: ______________ mm __ Less than: ______________ mm __ Greater than: ______________ mm __ Other (specify): ______________ __ Cannot be determined (explain): ______________ +Closest Margin(s) to Invasive Carcinoma (select all that apply) __ Anterior __ Posterior __ Superior __ Inferior __ Medial ✓ Lateral __ Other (specify): ______________ __ Cannot be determined (explain): ______________ Margin(s) Involved by Invasive Carcinoma (select all that apply) __ Anterior (specify extent): ______________ __ Posterior (specify extent): ______________ __ Superior (specify extent): ______________ __ Inferior (specify extent): ______________ __ Medial (specify extent): ______________ __ Lateral (specify extent): ______________ __ Other (specify margin(s) and extent): ______________ __ Cannot be determined (explain): ______________ __ Other (specify): ______________ __ Cannot be determined (explain): ______________ Regional Lymph Node Status __ Not applicable (no regional lymph nodes submitted or found) ✓ Regional lymph nodes present __ All regional lymph nodes negative for tumor __ Tumor present in regional lymph node(s) Number of Lymph Nodes with Macrometastases (greater than 2 mm) __ Exact number (specify): ______________ __ At least (specify): ______________ __ Other (specify): ______________ __ Cannot be determined (explain): ______________ Number of Lymph Nodes with Micrometastases (greater than 0.2 mm to 2 mm and / or greater than 200 cells) __ Exact number (specify): ______________ __ At least (specify): ______________ __ Other (specify): ______________ __ Cannot be determined (explain): ______________ Number of Lymph Nodes with Isolated Tumor Cells (0.2 mm or less OR 200 cells or less) (required only if applicable) __ Not applicable __ Exact number (specify): ______________ __ At least (specify): ______________ __ Other (specify): ______________ __ Cannot be determined (explain): ______________ Size of Largest Nodal Metastatic Deposit Specify in Millimeters (mm): __ Exact size: ______________ mm __ Less than: ______________ mm __ Greater than: ______________ mm __ Other (specify): ______________ __ Cannot be determined (explain): ______________ Extranodal Extension __ Not identified __ Present, 2 mm or less __ Present, greater than 2 mm +Specify Amount: __ Present __ Cannot be determined: ______________ __ Other (specify): ______________ __ Cannot be determined (explain): ______________ Total Number of Lymph Nodes Examined (sentinel and non-sentinel) ✓ Exact number (specify): ______________ __ At least (specify): ______________ __ Other (specify): ______________ __ Cannot be determined (explain): ______________ Number of Sentinel Nodes Examined (if applicable) __ Not applicable ✓ Exact number (specify): ______________ __ At least (specify): ______________ __ Other (specify): ______________ __ Cannot be determined (explain): ______________ Distant Site(s) Involved, if applicable (select all that apply) ✓ Not applicable __ Non-regional lymph node(s) (specify, if possible): ______________ __ Lung: ______________ __ Liver: ______________ __ Bone: ______________ __ Brain: ______________ __ Other (specify): ______________ __ Cannot be determined Modified Classification (required only if applicable) (select all that apply) __ Not applicable __ y (post-neoadjuvant therapy) __ r (recurrence) pT Category __ pT not assigned (cannot be determined based on available pathological information) __ pT0: No evidence of primary tumor __ pTis (DCIS): Ductal carcinoma in situ __ pTis (Paget): Paget disease NOT associated with invasive carcinoma and / or carcinoma in situ (DCIS) in the underlying breast parenchyma __ pT1: Tumor less than or equal to 20 mm in greatest dimension __ pT1mi: Tumor less than or equal to 1 mm in greatest dimension __ pT1a: Tumor greater than 1 mm but less than or equal to 5 mm in greatest dimension ✓ pT1b: Tumor greater than 5 mm but less than or equal to 10 mm in greatest dimension __ pT1c: Tumor greater than 10 mm but less than or equal to 20 mm in greatest dimension __ pT2: Tumor greater than 20 mm but less than or equal to 50 mm in greatest dimension __ pT3: Tumor greater than 50 mm in greatest dimension __ pT4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules) __ pT4a: Extension to the chest wall; invasion of or adherence to pectoralis muscle in the absence of invasion of chest wall structures does not qualify as T4 __ pT4b: Ulceration and/or ipsilateral satellite nodules and/or edema (including peau d'orange) of the skin which do not meet the criteria for inflammatory carcinoma __ pT4c: Both T4a and T4b are present __ pT4d: Inflammatory carcinoma __ pT4 (subcategory cannot be determined) pN Category __ pN not assigned (no nodes submitted or found) __ pN not assigned (cannot be determined based on available pathological information) ✓ pN0: No regional lymph node metastasis identified or ITCs only __ pN0 (i+): ITCs only (malignant cell clusters no larger than 0.2 mm) in regional lymph node(s) __ pN0 (mol+): Positive molecular findings by reverse transcriptase polymerase chain reaction (RT-PCR); no ITCs detected __ pN1: Metastases in 1 to 3 axillary lymph nodes, at least one metastasis larger than 2.0 mm __ pN1mi: Micrometastases (approximately 200 cells, larger than 0.2 mm, but none larger than 2.0 mm) __ pN1a: Metastases in 1 to 3 axillary lymph nodes, at least one metastasis larger than 2.0 mm __ pN1b: Metastases in internal mammary sentinel nodes, excluding ITCs __ pN1c: pN1a and pN1b combined __ pN2: Metastases in 4-9 axillary lymph nodes; or in clinically detected internal mammary lymph nodes with negative axillary nodes __ pN2a: Metastases in 4-9 axillary lymph nodes (at least one tumor deposit larger than 2.0 mm) __ pN2b: Metastases in clinically detected internal mammary lymph nodes with or without microscopic confirmation; with pathologically negative axillary lymph nodes __ pN3: Metastases in 10 or more axillary lymph nodes; or in infraclavicular (level III axillary) lymph nodes; or in clinically detected ipsilateral internal mammary lymph nodes with one or more positive level I, II axillary lymph nodes; or in more than 3 axillary lymph nodes and in internal mammary lymph nodes with microscopic disease or macroscopic disease detected by sentinel lymph node biopsy but not clinically detected; or in ipsilateral supraclavicular lymph nodes __ pN3a: Metastases in 10 or more axillary lymph nodes (at least one tumor deposit larger than 2.0 mm); or metastases to the infraclavicular (level III axillary lymph) nodes __ pN3b: pN1a or pN2a in the presence of cN2b (positive internal mammary nodes by imaging); or pN2a in the presence of pN1b __ pN3c: Metastases in ipsilateral supraclavicular lymph nodes N Suffix (required only if applicable) __ Not applicable __ (sn) Sentinel node(s) evaluated. If 6 or more nodes (sentinel or nonsentinel) are removed, this modifier should not be used __ (f) Nodal metastasis confirmed by fine needle aspiration or core needle biopsy __ (m) Multiple primary synchronous tumors in a single organ ADDITIONAL FINDINGS (Note O) +Additional Findings (specify): ________________ SPECIAL STUDIES The CAP Breast Biomarker Template should be used for reporting biomarkers requested for this resection specimen. Pending biomarker studies should be listed in the Comments section of this report. +Breast Biomarker Studies Performed on Previous Biopsy (select all that apply) ✓ Estrogen Receptor (ER) Estrogen Receptor (ER) Status __ Positive (greater than 10% of cells demonstrate nuclear positivity) __ Low Positive (1-10% of cells with nuclear positivity) __ Negative ✓ Cannot be determined (indeterminate) __ Progesterone Receptor (PgR) ✓ HER2 (by immunohistochemistry) ✓ Negative (Score 0) __ Negative (Score 1+) __ Equivocal (Score 2+) __ Positive (Score 3+) __ Cannot be determined (indeterminate) __ HER2 (by in situ hybridization)
Generated Narrative: DiagnosticReport diagnosticreport-breast-invasive-carcinoma Profile: US Pathology Diagnostic Report Pathology Synoptic report (Pathology) Subject Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) When For 2025-03-18 21:39:30+0000 Performer PractitionerRole Primary Interpreter Identifier <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:7c9139fe-ddd5-49d9-b649-f37344e8b995 Report Details Code Value Flags When For SPECIMEN Final 2025-03-18 TUMOR Final 2024-12-05 Tumor Extent (Note H) Final 2025-03-18 14:52:02+0000 --> (ongoing) Lymph Nodes Final 2025-03-18 MARGINS (Note L) Final 2025-03-18 REGIONAL LYMPH NODES (Note M) Final 2025-03-18 Distant Metastasis Final 2025-03-18 PATHOLOGIC STAGE CLASSIFICATION (pTNM, AJCC 8th Edition) (Note M) Final 2025-03-18 ADDITIONAL FINDINGS (Note N) Final 2025-03-18 SPECIAL STUDIES Final 2025-03-18 COMMENTS Final 2025-03-18
Generated Narrative: Patient patient-OakleyAnnie Profile: US Core Patient Profile Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) Other Ids: CaliforniaDLN/patient-OakleyAnnie SHID/12446 (use: usual, ) FHIR/66574567 (use: usual, ) Contact Detail ph: 1-(303)555-1212(Home) annie.oakley@example.com 4348 Main Street Denver CO 80111 US Links: Also see: RelatedPerson Bill Hickok
Generated Narrative: Encounter encounter-uspath-specimen-collection Profile: US Core Encounter Profileversion: null6.1.0) identifier: http://example.com/fhir/encounters/123 status: Finished class: ActCode IMP: inpatient encounter (version = 9.0.0 ) type: Pathology consultation, comprehensive, records and specimen with report subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) basedOn: ServiceRequest Surgical pathology study participant individual: Practitioner Wise Owl participant individual: Practitioner Stains Alot
Pathology consultation, comprehensive, records and specimen with report
Generated Narrative: PractitionerRole practitionerrole-uspath-practitioner-oncologist Profile: US Pathology Related Practitioner Role practitioner: Practitioner Wise Owl organization: Organization Redwood Women's Center, P.C. code: Ordering Provider telecom: ph: 720-242-5555
Generated Narrative: Observation observation-section-specimen Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:6ac70450-cc74-4a8e-8699-9ffab1e0ac24 status: Final category: Section code: SPECIMEN subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 performer: Practitioner Wise Owl hasMember: Observation Procedure (Note A) Observation Specimen Laterality
Generated Narrative: ServiceRequest servicerequest-cancer-path Profile: US Pathology Service Request status: Active intent: Order category: Pathology code: Surgical Pathology subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) encounter: Encounter: identifier = http://example.com/fhir/encounters#123; status = finished; class = inpatient encounter (ActCode[9.0.0]#IMP); type = Pathology consultation, comprehensive, records and specimen with report occurrence: 2025-03-18 17:00:14-0500 requester: PractitionerRole Ordering Provider specimen: Specimen: identifier = https://www.example.org/some-lis/fhir/specimen-identifier-provisioner#987654321; accessionIdentifier = https://www.example.org/some-lis/fhir/specimen-identifier-provisioner#987654321X; type = Tissue specimen (specimen)
Generated Narrative: PractitionerRole practitionerrole-uspath-pathologist Profile: US Pathology Related Practitioner Role practitioner: Practitioner Stains Alot organization: Organization Some Pathology Lab Name code: Primary Interpreter telecom: ph: 720-242-9999
Generated Narrative: Specimen specimen-breast Profile: US Pathology Specimen identifier: https://www.example.org/some-lis/fhir/specimen-identifier-provisioner/987654321 accessionIdentifier: https://www.example.org/some-lis/fhir/specimen-identifier-provisioner/987654321X type: Tissue specimen (specimen) request: ServiceRequest Surgical pathology study Collections - Collected[x] Method BodySite * 2025-03-18 17:00:14-0500 Excision (procedure) Right breast, 8 o'clock, 4 cm from nipple Containers - Identifier Type * https://www.example.org/some-lis/fhir/specimen-containerID-provisioner/123456789 Specimen container (physical object)
Right breast, 8 o'clock, 4 cm from nipple
Generated Narrative: Observation observation-section-tumor Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:cb7657fb-8127-41ef-9912-8f6fc52a5f85 status: Final category: Section code: TUMOR subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2024-12-05 performer: Practitioner Wise Owl hasMember: Observation Tumor Site (Note B) Observation Histologic Type (Note C) Observation Histologic Grade (Nottingham Histologic Score) (required only if applicable) (Note D) Observation Tumor Size (Note E) Observation Tumor Focality (Note F) Observation Ductal Carcinoma In Situ (DCIS) (Note G)
Generated Narrative: Observation observation-section-tumor-extent Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:1dc64a64-e4f1-4996-87df-28b76446c35a status: Final category: Section code: Tumor Extent (Note H) subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 14:52:02+0000 --> (ongoing) performer: Practitioner Wise Owl derivedFrom: Observation TUMOR
Generated Narrative: Observation observation-section-lymph-nodes Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:a0d2cb8e-ab6f-4efe-ad2b-03c20d625a9f status: Final category: Section code: Lymph Nodes subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 performer: Practitioner Wise Owl
Generated Narrative: Observation observation-section-margins Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:a0d2cb8e-ab6f-4efe-ad2b-03c20d625a9f status: Final category: Section code: MARGINS (Note L) subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 performer: Practitioner Wise Owl hasMember: Observation Margin Status for Invasive Carcinoma
Generated Narrative: Observation observation-section-regional-lymph-nodes Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:a0d2cb8e-ab6f-4efe-ad2b-03c20d625a9f status: Final category: Section code: REGIONAL LYMPH NODES (Note M) subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 performer: Practitioner Wise Owl hasMember: Observation Regional Lymph Node Status
Generated Narrative: Observation observation-section-distant-metastasis Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:a0d2cb8e-ab6f-4efe-ad2b-03c20d625a9f status: Final category: Section code: Distant Metastasis subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 performer: Practitioner Wise Owl hasMember: Observation DISTANT METASTASIS
Generated Narrative: Observation observation-section-ptnm-classification Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:4958b036-f88e-470b-b225-38e9fe6b6541 status: Final category: Section code: PATHOLOGIC STAGE CLASSIFICATION (pTNM, AJCC 8th Edition) (Note M) subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 performer: Practitioner Wise Owl hasMember: Observation pT Category Observation pN Category
PATHOLOGIC STAGE CLASSIFICATION (pTNM, AJCC 8th Edition) (Note M)
Generated Narrative: Observation observation-section-additional-findings Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:7c9139fe-ddd5-49d9-b649-f37344e8b995 status: Final category: Section code: ADDITIONAL FINDINGS (Note N) subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 performer: Practitioner Wise Owl hasMember: Observation Additional Findings (specify)
Generated Narrative: Observation observation-section-special-studies Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:87335ed1-f468-4061-a401-8b8e3b54cf4c status: Final category: Section code: SPECIAL STUDIES subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 performer: Practitioner Wise Owl hasMember: Observation Breast Biomarker Testing Performed on Previous Biopsy
Generated Narrative: Observation observation-section-comments Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/uuid:c3189cd4-33a0-447f-9bbf-2b225e2aa305 status: Final category: Section code: COMMENTS subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 performer: Practitioner Wise Owl
Generated Narrative: Practitioner practitioner-oncologist Profile: US Core Practitioner Profile identifier: NPI/1234567893 name: Wise Owl
Generated Narrative: Observation observation-procedure-breast-excision Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:7c9139fe-ddd5-49d9-b649-f37344e8b995 status: Final category: Question code: Procedure (Note A) subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 14:52:02+0000 --> (ongoing) performer: Practitioner Wise Owl value: Excision (less than total mastectomy) derivedFrom: Observation SPECIMEN
Specimen collection procedure (observable entity)
Generated Narrative: Observation observation-specimen-laterality Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:4bcd147c-ff3d-4eb3-bcd3-9d679bd1ad1b status: Final category: Question code: Specimen Laterality subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 14:52:02+0000 --> (ongoing) performer: Practitioner Wise Owl value: Right derivedFrom: Observation SPECIMEN
Generated Narrative: Observation observation-tumor-site Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:79ab15c8-4b0e-48e5-a477-7f72e62c002b status: Final category: Question code: Tumor Site (Note B) subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 14:52:02+0000 --> (ongoing) performer: Practitioner Wise Owl hasMember: Observation Clock position derivedFrom: Observation TUMOR
Anatomic location of primary malignant neoplasm (observable entity)
Generated Narrative: Observation observation-histologic-type Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:cb7657fb-8127-41ef-9912-8f6fc52a5f85 status: Final category: Question code: Histologic Type (Note C) subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 performer: Practitioner Wise Owl value: Invasive carcinoma of no special type (ductal)
Invasive carcinoma of no special type (ductal)
Generated Narrative: Observation observation-histologic-grade Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:cb7657fb-8127-41ef-9912-8f6fc52a5f85 status: Final category: Question code: Histologic Grade (Nottingham Histologic Score) (required only if applicable) (Note D) subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 14:52:02+0000 --> (ongoing) performer: Practitioner Wise Owl value: Nottingham Score hasMember: Observation Glandular (Acinar) / Tubular Differentiation Observation Nuclear Pleomorphism Observation Mitotic Rate Observation Overall Grade derivedFrom: Observation TUMOR
Histologic Grade (Nottingham Histologic Score) (required only if applicable) (Note D)
Generated Narrative: Observation observation-tumor-size Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:66153175-f304-443e-99cb-4058f350248b status: Final category: Question code: Tumor Size (Note E) subject: Annie Oakley effective: 2025-03-18 14:52:02+0000 --> (ongoing) performer: PractitionerRole Primary Interpreter value: Greatest dimension of largest invasive focus greater than 1 mm (specify exact measurement in Millimeters (mm)) hasMember: Observation Additional Dimension in Millimeters (mm) derivedFrom: Observation TUMOR
Greatest dimension of largest invasive focus greater than 1 mm (specify exact measurement in Millimeters (mm))
Greatest length dimension of excised primary malignant neoplasm (observable entity)
Generated Narrative: Observation observation-tumor-focality Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:309f8a1c-8311-4751-8718-4b2573a09633 status: Final category: Question code: Tumor Focality (Note F) subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 14:52:02+0000 --> (ongoing) performer: Practitioner Wise Owl value: Single focus of invasive carcinoma derivedFrom: Observation TUMOR
Generated Narrative: Observation observation-ductal-carcinoma Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:c2f916f9-7438-4ba6-9cba-9e9064edbe3c status: Final category: Question code: Ductal Carcinoma In Situ (DCIS) (Note G) subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 14:52:02+0000 --> (ongoing) performer: Practitioner Wise Owl value: Not identified derivedFrom: Observation TUMOR
Ductal Carcinoma In Situ (DCIS) (Note G)
Generated Narrative: Observation observation-margins-margin-status-for-invasive-carcinoma Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:ee170d9a-d5b5-481a-ac58-52dea11955b4 status: Final category: Question code: Margin Status for Invasive Carcinoma subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 14:52:02+0000 --> (ongoing) performer: Practitioner Wise Owl value: All margins negative for invasive carcinoma hasMember: Observation Distance from Invasive Carcinoma to Closest Margin Observation Closest Margin(s) to Invasive Carcinoma derivedFrom: Observation MARGINS (Note L)
All margins negative for invasive carcinoma
Generated Narrative: Observation observation-regional-lymph-node-status Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:a0d2cb8e-ab6f-4efe-ad2b-03c20d625a9f status: Final category: Question code: Regional Lymph Node Status subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 performer: Practitioner Wise Owl value: Regional lymph nodes present hasMember: Observation Total Number of Lymph Nodes Examined (sentinel and non-sentinel) Observation Number of Sentinel Nodes Examined derivedFrom: Observation REGIONAL LYMPH NODES (Note M)
Generated Narrative: Observation observation-distant-metastasis Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:a0d2cb8e-ab6f-4efe-ad2b-03c20d625a9f status: Final category: Section code: DISTANT METASTASIS subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 performer: Practitioner Wise Owl hasMember: Observation Distant Site(s) Involved, if applicable
Generated Narrative: Observation observation-ptnm-classification-pT-Category Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:4958b036-f88e-470b-b225-38e9fe6b6541 status: Final category: Question code: pT Category subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 performer: Practitioner Wise Owl value: pT1b: Tumor greater than 5 mm but less than or equal to 10 mm in greatest dimension derivedFrom: Observation PATHOLOGIC STAGE CLASSIFICATION (pTNM, AJCC 8th Edition) (Note M)
pT1b: Tumor greater than 5 mm but less than or equal to 10 mm in greatest dimension
Generated Narrative: Observation observation-ptnm-classification-pN-Category Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:7164b3a9-3061-4f7f-9bbb-2a4e6980d665 status: Final category: Question code: pN Category subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 performer: Practitioner Wise Owl value: pN0: No regional lymph node metastasis identified or ITCs only# derivedFrom: Observation PATHOLOGIC STAGE CLASSIFICATION (pTNM, AJCC 8th Edition) (Note M)
pN0: No regional lymph node metastasis identified or ITCs only#
Generated Narrative: Observation observation-additional-findings-specify Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:9cfaa1f6-f0af-4e66-8fe0-130b2143b135 status: Final category: Question code: Additional Findings (specify) subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 performer: Practitioner Wise Owl derivedFrom: Observation ADDITIONAL FINDINGS (Note N)
Generated Narrative: Observation observation-special-studies-breast-biomarker Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:3a313831-c8c5-44e7-8df2-af1b47b9879f status: Final category: Question code: Breast Biomarker Testing Performed on Previous Biopsy subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 performer: Practitioner Wise Owl hasMember: Observation Estrogen Receptor (ER) Observation HER2 (by immunohistochemistry) derivedFrom: Observation SPECIAL STUDIES
Breast Biomarker Testing Performed on Previous Biopsy
Generated Narrative: Observation observation-clock-position Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:ab9326c2-e1fe-4ba0-873c-41c923c7f772 status: Final category: Question code: Clock position subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 14:52:02+0000 --> (ongoing) performer: Practitioner Wise Owl value: Clock position hasMember: Observation Specify Clock Position derivedFrom: Observation Tumor Site (Note B)
Generated Narrative: Observation observation-clock-position-8 Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:bf778f95-b1a8-4674-a73e-1f2dc0bfbdc4 status: Final category: Question code: Specify Clock Position subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-13 14:52:02+0000 --> (ongoing) performer: Practitioner Wise Owl value: 8 o'clock
Radial location of primary malignant neoplasm in excised breast specimen (observable entity)
Generated Narrative: Observation observation-glandular-differentiation Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:f0d0b23b-f6a0-44d4-bfaf-ade1b485c0b0 status: Final category: Question code: Glandular (Acinar) / Tubular Differentiation subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 14:52:02+0000 --> (ongoing) performer: Practitioner Wise Owl value: Score 2 (10 to 75% of tumor area forming glandular / tubular structures) derivedFrom: Observation Histologic Grade (Nottingham Histologic Score) (required only if applicable) (Note D)
Glandular (Acinar) / Tubular Differentiation
Score 2 (10 to 75% of tumor area forming glandular / tubular structures)
Generated Narrative: Observation observation-nuclear-pleomorphism Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:77d0563d-3685-4316-9a81-fa7d04d0d8d2 status: Final category: Question code: Nuclear Pleomorphism subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 14:52:02+0000 --> (ongoing) performer: Practitioner Wise Owl value: Score 2 (Cells larger than normal with open vesicular nuclei, visible nucleoli, and moderate variability in both size and shape) derivedFrom: Observation Histologic Grade (Nottingham Histologic Score) (required only if applicable) (Note D)
Score 2 (Cells larger than normal with open vesicular nuclei, visible nucleoli, and moderate variability in both size and shape)
Generated Narrative: Observation observation-mitotic-rate Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:814dd523-9284-4edb-8831-fc1c440e4979 status: Final category: Question code: Mitotic Rate subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 14:52:02+0000 --> (ongoing) performer: Practitioner Wise Owl value: Score 1 derivedFrom: Observation Histologic Grade (Nottingham Histologic Score) (required only if applicable) (Note D)
Generated Narrative: Observation observation-overall-grade Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:ddea4bbc-a3e7-477b-b279-57cf5071e0b9 status: Final category: Question code: Overall Grade subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2024-12-05 14:52:02+0000 --> (ongoing) performer: Practitioner Wise Owl value: Grade 1 (scores of 3, 4 or 5) derivedFrom: Observation Histologic Grade (Nottingham Histologic Score) (required only if applicable) (Note D)
Generated Narrative: Observation observation-additional-dimension Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:18c9ea9c-ddf2-400d-adea-07c97dd7b016 status: Final category: Question code: Additional Dimension in Millimeters (mm) subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 14:52:02+0000 --> (ongoing) performer: Practitioner Wise Owl value: 13 derivedFrom: Observation Tumor Size (Note E)
Additional Dimension in Millimeters (mm)
Generated Narrative: Observation observation-margins-distance-to-closest-margin Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:7069b59e-9414-4838-bd6d-674ef97c414c status: Final category: Question code: Distance from Invasive Carcinoma to Closest Margin subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 14:52:02+0000 --> (ongoing) performer: Practitioner Wise Owl value: Exact distance derivedFrom: Observation Margin Status for Invasive Carcinoma
Distance from Invasive Carcinoma to Closest Margin
Generated Narrative: Observation observation-margins-closest-margin-to-invasive-carcinoma Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:c12982a8-541c-469a-b016-9468d58eb858 status: Final category: Question code: Closest Margin(s) to Invasive Carcinoma subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 14:52:02+0000 --> (ongoing) performer: Practitioner Wise Owl value: Lateral derivedFrom: Observation MARGINS (Note L)
Generated Narrative: Observation observation-regional-lymph-nodes-number-examined Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:a903ae85-913a-4c9b-94cb-c6a1e00340e3 status: Final category: Question code: Total Number of Lymph Nodes Examined (sentinel and non-sentinel) subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 performer: Practitioner Wise Owl value: Exact number (specify) derivedFrom: Observation Regional Lymph Node Status
Total Number of Lymph Nodes Examined (sentinel and non-sentinel)
Generated Narrative: Observation observation-regional-lymph-nodes-number-sentinel Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:25b43d87-bad0-4779-91c8-352ad2f778ce status: Final category: Question code: Number of Sentinel Nodes Examined subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 performer: Practitioner Wise Owl value: Exact number (specify) derivedFrom: Observation Regional Lymph Node Status
Generated Narrative: Observation observation-distant-metastasis-distant-sites Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:a0d2cb8e-ab6f-4efe-ad2b-03c20d625a9f status: Final category: Question code: Distant Site(s) Involved, if applicable subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 performer: Practitioner Wise Owl value: Not applicable derivedFrom: Observation DISTANT METASTASIS
Generated Narrative: Observation observation-special-studies-estrogen-receptor Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:8e615e45-6a49-46d9-8dfe-e84f19c29a92 status: Final category: Question code: Estrogen Receptor (ER) subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-05 performer: Practitioner Wise Owl value: Estrogen Receptor (ER) hasMember: Observation Estrogen Receptor (ER) Status derivedFrom: Observation Breast Biomarker Testing Performed on Previous Biopsy
Generated Narrative: Observation observation-special-studies-her2 Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:deacb965-18d3-4451-a27f-0e26e7a9e5a2 status: Final category: Question code: HER2 (by immunohistochemistry) subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 performer: Practitioner Stains Alot hasMember: Observation HER2 (by immunohistochemistry) derivedFrom: Observation Breast Biomarker Testing Performed on Previous Biopsy
Generated Narrative: Observation observation-special-studies-estrogen-receptor-status Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:32bd9a78-878b-4fda-a6bd-c0bc58109fe7 status: Final category: Question code: Estrogen Receptor (ER) Status subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 performer: Practitioner Wise Owl value: Cannot be determined (indeterminate) derivedFrom: Observation Estrogen Receptor (ER)
Generated Narrative: Practitioner practitioner-pathologist Profile: US Core Practitioner Profile identifier: NPI/1234567893 name: Stains Alot
Generated Narrative: Observation observation-special-studies-negative Profile: US Pathology Observation identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title=""The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies."#xD;#xA;#xD;#xA;"The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).#xD;#xA;#xD;#xA;The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).#xD;#xA;#xD;#xA;The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry."#xD;#xA;#xD;#xA;"The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users." For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC/urn:uuid:1ca2fb51-1752-4489-a4b0-5c0dccc043e5 status: Final category: Question code: HER2 (by immunohistochemistry) subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) effective: 2025-03-18 performer: Practitioner Wise Owl value: Negative (Score 0) derivedFrom: Observation HER2 (by immunohistochemistry)
Generated Narrative: RelatedPerson relatedperson-pathology-next-of-kin Profile: US Core RelatedPerson Profile active: true patient: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, )) relationship: Next-of-Kin name: Bill Hickok telecom: ph: 1-989-654-7896
Generated Narrative: PractitionerRole practitionerrole-uspath-surgeon Profile: US Pathology Related Practitioner Role practitioner: Practitioner Cuts Alot organization: Organization Redwood Women's Center, P.C. code: Ordering Provider telecom: ph: 720-242-5555
Generated Narrative: Organization organization-Redwood-Womens-Center-PC Profile: US Core Organization Profile active: true name: Redwood Women's Center, P.C. address: 3307 Renner Drive Fortuna CA 95540 USA
Generated Narrative: Organization organization-principal-pathology-lab Profile: US Core Organization Profile active: true name: Some Pathology Lab Name address: Any City CA 95540 USA
Generated Narrative: Practitioner practitioner-surgeon Profile: US Core Practitioner Profile identifier: NPI/1234567893 name: Cuts Alot